Literature DB >> 510102

American diabetes association policy statement: the UGDP controversy.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 510102

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

Review 1.  A rational approach to drug therapy of type 2 diabetes mellitus.

Authors:  J M Chehade; A D Mooradian
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 2.  Are sulfonylureas passé?

Authors:  Jennifer B Green; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 3.  Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors:  P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 4.  The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?

Authors:  Laurentiu M Pop; Ildiko Lingvay
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

5.  Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum.

Authors:  William T Cefalu; John B Buse; Stefano Del Prato; Philip D Home; Derek LeRoith; Michael A Nauck; Itamar Raz; Julio Rosenstock; Matthew C Riddle
Journal:  Diabetes Care       Date:  2014-09       Impact factor: 19.112

6.  Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis.

Authors:  Samuel S Engel; Gregory T Golm; Deborah Shapiro; Michael J Davies; Keith D Kaufman; Barry J Goldstein
Journal:  Cardiovasc Diabetol       Date:  2013-01-03       Impact factor: 9.951
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.